Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049448

EVP, R&D & Chief Scientific Of sold 7,604 shares at $14.75 ($112,159)

  • EVP, R&D & Chief Scientific Of acquired 829 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2017-08-15 Option exercise +829 362,909 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2017-08-15 Sale −7,604 $14.75 $112,159 355,305 D
Derivatives
Haqq Christopher EVP, R&D & Chief Scientific Of 2017-08-15 Option exercise · Restricted Stock Units −829 1,382 D
Open-market sales · 7,604 sh · avg $14.75 · $112,159
Loading xslF345X03/doc4.xml…